Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication

Expert Review of Neurotherapeutics - Tập 15 Số 1 - Trang 7-17 - 2015
William James Deardorff1, Ahmad Shobassy1, George T. Grossberg1
1St. Louis University School of Medicine, 1438 South Grand St Louis, MO 63104, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

2014, Alzheimer’s Dementia, 10, e47, 10.1016/j.jalz.2014.02.001

10.1212/WNL.0b013e31828726f5

Hurd MD, 2013, N Engl J Med, 369, 489, 10.1056/NEJMc1305541

Lanctôt KL, 2009, Ther Adv Neurol Disord, 2, 163, 10.1177/1756285609102724

Birks J, 2006, Cochrane Database Syst Rev, CD005593

Hansen RA, 2008, Clin Interv Aging, 3, 211

Reisberg B, 2003, N Engl J Med, 348, 1333, 10.1056/NEJMoa013128

Lin CH, 2014, Curr Pharm Des, 20, 5169, 10.2174/1381612819666140110115603

10.1016/S1474-4422(10)70119-8

Levin ED, 2006, Psychopharmacology (Berl), 184, 523, 10.1007/s00213-005-0164-7

Rezvani AH, 2001, Biol Psychiatry, 49, 258, 10.1016/S0006-3223(00)01094-5

Young JW, 2013, Biochem Pharmacol, 86, 1122, 10.1016/j.bcp.2013.06.031

Dani JA, 2007, Annu Rev Pharmacol Toxicol, 47, 699, 10.1146/annurev.pharmtox.47.120505.105214

Jensen AA, 2005, J Med Chem, 48, 4705, 10.1021/jm040219e

Gotti C, 2006, Trends Pharmacol Sci, 27, 482, 10.1016/j.tips.2006.07.004

Livingstone P, 2010, J Mol Neurosci, 40, 172, 10.1007/s12031-009-9232-5

Vallés AS, 2014, CNS Drugs, 28, 975, 10.1007/s40263-014-0201-3

Gotti C, 2009, Biochem Pharmacol, 78, 703, 10.1016/j.bcp.2009.05.024

Nordberg A, 2010, Nat Rev Neurol, 6, 78, 10.1038/nrneurol.2009.217

Hernandez CM, 2010, J Neurosci, 30, 2442, 10.1523/JNEUROSCI.5038-09.2010

Paterson D, 2000, Prog Neurobiol, 61, 75, 10.1016/S0301-0082(99)00045-3

Wang HY, 2000, J Biol Chem, 275, 5626, 10.1074/jbc.275.8.5626

Ono K, 2002, Biol Psychiatry, 52, 880, 10.1016/S0006-3223(02)01417-8

Inestrosa NC, 2013, Neuromolecular Med, 15, 549, 10.1007/s12017-013-8242-1

Kroker KS, 2013, Brain Res Bull, 96, 28, 10.1016/j.brainresbull.2013.04.006

Gault L, 2013, Alzheimer’s Dementia, 9, P138, 10.1016/j.jalz.2013.04.081

Gault LM, 2014, Alzheimer’s Dementia, 10, P917, 10.1016/j.jalz.2014.07.123

Othman A, 2014, Alzheimer’s Dementia, 10, P137, 10.1016/j.jalz.2014.04.081

Prickaerts J, 2012, Neuropharmacology, 62, 1099, 10.1016/j.neuropharm.2011.10.024

Huang M, 2014, Psychopharmacology (Berl), 231, 4541, 10.1007/s00213-014-3596-0

Wallace TL, 2011, J Pharmacol Exp Ther, 336, 242, 10.1124/jpet.110.171892

Hauser TA, 2009, Biochem Pharmacol, 78, 803, 10.1016/j.bcp.2009.05.030

Malysz J, 2010, J Pharmacol Exp Ther, 334, 863, 10.1124/jpet.110.167072

Sydserff S, 2009, Biochem Pharmacol, 78, 880, 10.1016/j.bcp.2009.07.005

Wishka DG, 2006, J Med Chem, 49, 4425, 10.1021/jm0602413

Bitner RS, 2010, J Pharmacol Exp Ther, 334, 875, 10.1124/jpet.110.167213

Barbier AJ, 2014, Clin Ther

Kuan S, 2013, Alzheimer’s Dementia, 9, P660, 10.1016/j.jalz.2013.05.1356

Rosen WG, 1984, Am J Psychiatry, 141, 1356, 10.1176/ajp.141.11.1356

Raina P, 2008, Ann Intern Med, 148, 379, 10.7326/0003-4819-148-5-200803040-00009

Qaseem A, 2008, Ann Intern Med, 148, 370, 10.7326/0003-4819-148-5-200803040-00008

Tan CC, 2014, J Alzheimers Dis, 41, 615, 10.3233/JAD-132690

National Institute for Health and Clinical Excellence (NICE). Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. London (UK): National Institute for Health and Clinical Excellence (NICE); 2011

Darby DG, 2012, Alzheimers Dement, 8, 95, 10.1016/j.jalz.2010.12.009

Maruff P, 2013, BMC Psychol, 1, 1, 10.1186/2050-7283-1-30

Cedarbaum JM, 2013, Alzheimers Dement, 9, S45, 10.1016/j.jalz.2011.11.002

Harrison J, 2007, Arch Neurol, 64, 1323, 10.1001/archneur.64.9.1323

Hilt D, 2009, Alzheimer’s Dementia, 5, e32, 10.1016/j.jalz.2009.07.147

Hilt D, 2012, Alzheimer’s Dementia, 8, S746, 10.1016/j.jalz.2013.08.030

Rockwood K, 2004, J Neurol Neurosurg Psychiatry, 75, 677, 10.1136/jnnp.2003.029074

Cano SJ, 2010, J Neurol Neurosurg Psychiatry, 81, 1363, 10.1136/jnnp.2009.204008

Harrison J, 2013, Alzheimer’s Dementia, 9, P661, 10.1016/j.jalz.2013.05.1359

Preskorn SH, 2014, J Psychiatr Pract, 20, 12, 10.1097/01.pra.0000442935.15833.c5

Loewen G, 2013, Alzheimer’s Dementia, 9, P660, 10.1016/j.jalz.2013.05.1357

Cachelin AB, 1994, Mol Pharmacol, 46, 1168

Søderman A, 2008, Brain Res, 1227, 240, 10.1016/j.brainres.2008.06.062

Ren K, 2007, Neuroscience, 148, 230, 10.1016/j.neuroscience.2007.05.013

Parri HR, 2011, Biochem Pharmacol, 82, 931, 10.1016/j.bcp.2011.06.039